Post-Menopausal Bleeding

Clinical Scenario

Margaret Foster, 61, presents face-to-face with vaginal bleeding. She is 10 years post-menopause and not on HRT. She had two episodes of spotting over 3 weeks, followed by a 2-day episode of heavier bright red bleeding. The bleeding was painless. Her PMH includes hypertension, type 2 diabetes (diet controlled), and osteoarthritis. Her mother had breast cancer. Margaret is a retired teacher who lives alone and is worried but has been putting off the appointment because she is afraid of what it might mean.

What This Case Tests

Recognising post-menopausal bleeding as a red flag requiring urgent investigation; identifying endometrial cancer risk factors in this patient; initiating an urgent 2-week wait (2WW) cancer pathway referral; communicating the need for urgent referral honestly without causing panic; providing emotional support for a patient who is facing potential cancer investigation alone.

Common Mistakes Trainees Make

The three most common mistakes are: attributing the bleeding to a benign cause (atrophic vaginitis, cervical polyp) without initiating the 2WW pathway (all post-menopausal bleeding must be investigated urgently until cancer is excluded), being so focused on the referral that you fail to address Margaret's fear and isolation (she lives alone and has delayed seeking help because she is afraid), and not identifying the multiple endometrial cancer risk factors present (obesity, diabetes, hypertension, nulliparity).

The Consultation Challenge

Post-menopausal bleeding is cancer until proven otherwise. This is one of the clearest red flags in medicine, and the management pathway is unambiguous: every woman with post-menopausal bleeding (any vaginal bleeding 12+ months after the last period in a woman not on HRT) requires urgent gynaecological assessment via the 2-week wait suspected cancer pathway.

Start by taking a focused history of the bleeding: when it started, frequency, amount, colour, associated pain, and any precipitating factors. Confirm she is genuinely post-menopausal (last period approximately 10 years ago, not on HRT). Ask about other symptoms: weight loss, abdominal distension, pelvic pain, changes in bowel or bladder function.

Assess her risk factors for endometrial cancer. Margaret has several: age over 55, type 2 diabetes (associated with insulin resistance and oestrogen excess), hypertension, likely obesity (mentioned in the management plan), and possible nulliparity. Her mother's breast cancer is also relevant — there is a genetic overlap between breast and endometrial cancer risk (particularly Lynch syndrome). These risk factors increase the pre-test probability but do not change the management — all PMB requires urgent referral regardless of risk.

Now comes the most challenging part: communicating the need for urgent referral without causing panic, while being honest about why it is urgent. Margaret has delayed seeking help because she is afraid. If you are vague about why the referral is urgent, you risk her not attending. If you are too blunt, you risk overwhelming her.

A balanced approach: "Bleeding after the menopause always needs to be investigated promptly, and I want to be honest with you about why. In most cases, the cause is something straightforward — like thinning of the womb lining or a polyp. But occasionally it can be a sign of something more serious, which is why we investigate everyone urgently. I'm going to arrange a referral today so you can be seen within 2 weeks."

Address her isolation. Margaret lives alone. Ask whether she has someone who can accompany her to the appointment, whether she has support at home, and whether she would like follow-up from the practice while she waits. Offering a follow-up call shows pastoral care.

Time check: Spend the first 3 minutes on the bleeding history and red flag screening. By minute 5, identify the risk factors. Explain the 2WW referral between minutes 6-8 with honest but measured communication. Address Margaret's emotional state and isolation between minutes 9-11. Use the final minute for practical next steps.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess whether you take a focused bleeding history, confirm post-menopausal status, and identify risk factors for endometrial cancer. They look for screening of associated symptoms (weight loss, pelvic pain, abdominal distension) and exclusion of other bleeding sources (urinary, rectal). A brief examination plan (abdominal palpation, speculum if face-to-face) demonstrates thoroughness. The diagnostic conclusion should be clear: PMB requires urgent exclusion of endometrial cancer.

Clinical Management and Medical Complexity: Examiners expect immediate 2WW referral via the suspected cancer pathway. They look for knowledge of what the referral involves (transvaginal ultrasound, endometrial biopsy, seen within 14 days), awareness of the endometrial cancer risk factors present in this patient, and practical next steps (how Margaret will receive the appointment, what to do if bleeding worsens before the appointment). A trainee who investigates in primary care first (ordering bloods, arranging their own ultrasound) rather than referring urgently will score poorly.

Relating to Others: Examiners assess whether you communicate the urgency honestly but without causing panic, acknowledge Margaret's fear and delay in seeking help, address her isolation (living alone), and provide emotional support. The breaking bad news element is not about a cancer diagnosis (which has not been made) but about communicating the possibility of cancer in a way that is honest, measured, and supportive.

Example Opening

Strong opening: "Hello Margaret, thank you for coming in today. I understand you've noticed some bleeding, and I know that can be worrying — especially when you've put off coming in. Can you tell me exactly what's been happening?"

When explaining the referral: "I want to be straight with you, Margaret. Any bleeding after the menopause needs to be investigated properly and quickly. In most cases, the cause turns out to be something straightforward — like thinning of the womb lining. But we need to make sure it's nothing more serious, which is why I'm going to refer you to the hospital under an urgent pathway. You should be seen within 2 weeks."

When addressing her isolation: "Is there someone who could go with you to the hospital appointment? And would it help if I or one of the team called you in a few days to see how you're doing?"

Avoid: "I'm sure it's nothing to worry about." (Provides false reassurance for a genuine red flag).

How This Appears in the SCA

Post-menopausal bleeding is a classic SCA red flag recognition case. The examiner is testing whether you recognise the urgency, initiate the correct referral pathway immediately, communicate honestly with the patient, and provide holistic support. There is no clinical ambiguity here — the only correct action is urgent 2WW referral.

Key Statistic

Approximately 5-10% of women with post-menopausal bleeding are diagnosed with endometrial cancer. The 2-week wait pathway ensures rapid assessment — transvaginal ultrasound and endometrial biopsy are the standard investigations. Early-stage endometrial cancer has an excellent prognosis with 5-year survival exceeding 90%.

Relevant Guidelines

• NICE NG12: Suspected cancer — recognition and referral (2-week wait pathway)
• NICE guideline on endometrial cancer
• RCOG guidance on post-menopausal bleeding investigation.

Frequently Asked Questions

Is all post-menopausal bleeding an urgent referral?

Yes — all post-menopausal bleeding (any vaginal bleeding 12+ months after the last period in a woman not on HRT) requires urgent investigation via the 2-week wait suspected cancer pathway per NICE NG12. This applies regardless of the amount of bleeding (even a single episode of spotting), the patient's age, or the presence or absence of risk factors. There are no exceptions — investigate first, diagnose second.

What risk factors for endometrial cancer should I identify in the SCA?

Key risk factors include: age over 55, obesity (oestrogen production from adipose tissue), type 2 diabetes (associated with insulin resistance and hyperoestrogenism), hypertension, nulliparity, late menopause (after 55), tamoxifen use, Lynch syndrome (hereditary nonpolyposis colorectal cancer), and a family history of endometrial or colorectal cancer. Identifying multiple risk factors in this patient demonstrates thorough data gathering.

How do I communicate potential cancer investigation without causing panic?

Be honest, balanced, and practical. Name the concern without dramatising it: "We need to check this urgently to make sure it's nothing serious." Contextualise with statistics: "In most cases — about 9 out of 10 — the cause turns out to be something benign." Then move quickly to the plan: what happens next, when she will be seen, and what to do in the interim. Honesty paired with practical next steps reduces anxiety more effectively than vague reassurance.

What investigations does the 2WW referral involve?

The standard investigation pathway for post-menopausal bleeding includes transvaginal ultrasound (measuring endometrial thickness — typically considered abnormal if over 4-5mm in a post-menopausal woman not on HRT) and endometrial biopsy (pipelle or hysteroscopy-guided). The appointment should occur within 14 days of referral. The GP's role is to refer urgently — do not delay by arranging primary care investigations first.

What are the common benign causes of post-menopausal bleeding?

Atrophic vaginitis (thinning of vaginal tissue due to oestrogen deficiency) is the most common cause. Cervical or endometrial polyps, endometrial hyperplasia, and cervicitis are also common benign causes. However, even though 90-95% of cases are benign, you cannot make this determination without proper investigation. Always refer first — never reassure based on clinical assessment alone.